Conformal radiotherapy and intensity-modulated radiotherapy - Clinical data

Acta Oncologica

Volumn 39, Issue 5, 2000, Pages 555-567

  Tubiana, M ^a   Eschwege, F ^a  

^a Institut de Virologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; REVIEW;

EID: 0033770394     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750013249     Document Type: Review

References (111)

1. The biological basis for conformal three dimensional radiation therapy
2. Clinical and technical aspects of conformal therapy
3. Significance of ipsilateral breast tumour recurrence after lumpectomy
4. Breast cancer relationship between the size of the primary tumour and the probability of distant dissemination
5. The link between local recurrence and distant metastases in human breast cancer
6. The effect of local control on metastatic dissemination in carcinoma of the prostate long term results in patients treated with I 125 implantation
7. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database
8. The role of local treatment in the cure of cancer
9. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion
10. Local control and patient survival
11. Experimental studies on the incidence of metastases after failure of radiation treatment and the effect of salvage surgery
12. Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy vs. radical radiotherapy. Second report and review
13. Stage II carcinoma of the endometrium: Results of therapy, and prognostic factors
14. Local tumor control and the subsequent incidence of distant metastatic disease
15. The significance of local control in the primary treatment of breast cancer
16. Adequate loco-regional treatment of early breast cancer may prevent secondary dissemination
17. A meta-analysis of thoracie radiotherapy for small cell long cancer
18. Treatment of early breast cancer - A report after ten years of a clinical trial
19. Chemotherapy as an adjunct to definitive loco-regional treatment for head and neck squamour all carcinoma. Results of three meta-analysis using individual updated data
20. Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: The experience of the Gustave-Roussy Institute and the Margaret Hospital
21. Is the steepness of dose-incidence curves for tumour control or complications due to variation before or as a result of irradiation?
22. Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells
23. The results of treatment of cancer of the bladder - A clinical contribution to radiobiology
24. The statistical dose-cure relationships for irradiated tumors
25. Inter-tumor heterogeneity and radiation dose control curves
26. The effect of dose on local control of prostate cancer
27. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
28. Impact of changes in the treatment of nasopharyngeal carcinoma: An experience of 30 years
29. Carcinoma of the nasopharynx: Factors affecting prognosis
30. Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): Are higher doses beneficial?
31. Dose-response relationships for human tumors: Implications for clinical trials of dose modifying agents
32. An approach to the interpretation of the clinical data on the tumor control probability dose relationship
33. Regional stage IV of the nasopharynx treated by aggressive radiotherapy
34. Physical and biological predictors of changes in whole-lung function following thoracic irradiation
35. Dose-volume histogram and 3D treatment planning evaluation of patients with pneumonitis
36. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
37. Estimation of overall pulmonary function after irradiation using dose-effect relationship for local functional injury
38. Favourable and unfavourable effect on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials
39. Long term curative results of radiotherapy in patients with an inoperable prostatic carcinoma
40. Comments on the treatment of prostate cancer by conventional radiation therapy
41. Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > 10 ng/ml
42. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization and future directions
43. Intensity-modulated radiation therapy for prostate cancers: The Baylor experience
44. 3D conformal radiation therapy for prostate cancer. An update of RTOG 94-06
45. The New-England medical center prostate cancer IMRT experience
46. The 'critical volume tolerance method' for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer
47. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy
48. Prostate volumes and organ movement defined by serial CT scans during 3D conformal radiotherapy
49. Analysis of prostate and seminal vesicle motion: Implications for treatment planning
50. The effectiveness of immobilization during prostate irradiation
51. Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate
52. Electronic portal imaging
53. Measurement of prostate movement over the course of routine radiotherapy using implanted markers
54. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer
55. Accuracy of pelvic radiotherapy: Prospective analysis of 90 patients in a randomized trial of conformal versus conventional treatment
56. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial
57. The use of multi-leaf collimator for conformal radiotherapy in carcinomas of the prostate and nasopharynx
58. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
59. Locally advanced prostatic cancer: Long-term toxicity after three-dimensional conformal radiation therapy - A dose-escalation study
60. The treatment of localized prostate cancer with three-dimensional conformal and intensity modulated radiation therapy at the Memorial Sloan-Kettering Cancer Center
61. Three dimensional conformal radiotherapy for treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients
62. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer using dose-volume histograms
63. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect
64. Conventional versus conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity
65. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: Results of a self assessment questionnaire
66. Acute morbidity reduction using 3D-CRT for prostate carcinoma, a randomized study
67. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy
68. Clinical dose response curve of human epithelioma tumors
69. Modulated beam conformal radiotherapy for head and neck tumors
70. Three dimensional photon radiotherapy planning for laryngeal and hypopharyngeal cancers. 2 - Conformation treatment planning using multileaf collimator
71. A non-invasive immobilization system and related quality assurance for dynamic intensity modulated radiation therapy of intracranial and head and neck disease
72. Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients
73. Intensity modulated radiation therapy for head and neck carcinoma. The Baylor experience
74. The potential for sparing parotids and escalation of biologically effective dose with IMRT of head and neck cancers
75. Quality assurance of serial tomotherapy for head and neck patient treatments
76. Intensity modulated radiation therapy in head and neck cancers. The Mallinckrodt experience
77. Patterns of local-regional failure following parotid sparing conformal radiotherapy and multisegmental intensity modulated radiotherapy for head and neck cancers
78. 3D intensity modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma: The UCSF experience
79. Intensity modulated radiation therapy (IMRT) for pediatric brain and head and neck tumors. The Baylor experience
80. Conformal intensity modulated radiation therapy for the treatment of optic nerve sheath meningioma. The Baylor experience
81. Dose escalation to 100 + Gy using automated IMRT optimization
82. Preoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
83. Adjuvant radiotherapy in node-positive premenopausal women with breast cancer
84. Intensity modulated tangential beam irradiation of the intact breast
85. Intensity modulation for breast treatment using static multileaf collimators
86. Major complications and causes of death in patients treated for Hodgkin's disease
87. Survival outcome after Hodgkin's disease: A report from the International Data Base on Hodgkin's disease
88. Late mortality in young British National Lymphoma Investigation patients cured of Hodgkin's disease
89. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group
90. Long-term toxicity of early stage of Hodgkin's disease therapy: The EORTC experience
91. Long-term survival in Hodgkin's disease: Relative impact of mortality, second tumors, infection and cardiovascular disease
92. Long-term complications of treatment and causes of mortality after Hodgkin's disease
93. Hodgkin's disease: Complications of therapy and excess mortality
94. Pericarditis and myocardial infarctions after Hodgkin's disease therapy
95. Long-term complications of treatment and cancer mortality after Hodgkin's disease
96. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease
97. Future directions in 3D treatment planning and delivery: A physicist's perspective
98. Clinical and financial issues for intensity-modulated radiation therapy delivery
99. Comparison of three dimensional conformal radiation therapy and intensity modulated radiation therapy systems
100. Optimization and clinical use of multi-segment intensity-modulated radiation therapy for high dose conformal therapy
101. Volumetric visualization of head and neck CT data for treatment planning
102. Immobilizing and positioning patients for radiotherapy
103. Dose calculations for external photon beams in radiotherapy
104. The potential and limitations of the inverse radiotherapy technique
105. Advances in three-dimensional treatment planning and conformal dose delivery
106. Potential clinical efficacy of intensity modulated conformal radiotherapy
107. Where we go from here. One person's vision
108. Can modest escalations of dose be detected as increased tumor control
109. Optimization of the dose delivery in few field techniques using radiobiological objective functions